Herbal supplement added to rheumatoid arthritis treatment
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests whether a traditional Chinese herbal medicine, combined with your current rheumatoid arthritis medications, can reduce joint pain and swelling better than your current treatment alone. The study involves 6–12 months of treatment and regular check-ins with the research team.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21–70 years old and have been diagnosed with rheumatoid arthritis by a rheumatologist
- You have active RA with at least 6 swollen and 6 tender joints, confirmed by blood tests and physical exam
- You have been taking methotrexate (a standard RA medication) at a stable dose for at least 3 months
- You have not taken other RA drugs (like hydroxychloroquine or sulfasalazine) for at least 4 weeks before the study starts
- You have no serious infections, HIV, hepatitis, tuberculosis, or cancer; your blood counts and liver/kidney tests are normal
- If you are female and can become pregnant, you agree to use reliable birth control during the study and for 3 months after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding silymarin (a natural supplement from milk thistle) to standard methotrexate treatment can improve symptoms of rheumatoid arthritis. It may help reduce joint pain and swelling for people who are not yet in remission.
This trial combines traditional Chinese herbal medicine with standard Western treatments for people with rheumatoid arthritis that hasn't responded well to at least two prior medications. It aims to see if the combination is more effective and safe.
This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.
This trial tests an investigational drug for people with moderate-to-severe rheumatoid arthritis who haven't responded well to previous treatments. It aims to see if the drug can reduce joint pain and swelling.
This trial tests an investigational drug called JAB-8263 for people with active rheumatoid arthritis. It aims to see if the drug can help reduce inflammation and improve symptoms.
This study tests whether a new investigational drug called Natrunix, when combined with your usual methotrexate, can improve symptoms of moderate to severe rheumatoid arthritis. The goal is to reduce joint pain and swelling and help you feel better.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.